Gulf Coast TX
City Therapeutics eyes valuation of up to $956.3 million in US IPO amid biotech listing push
Oct 9 (Reuters) -- City Therapeutics on Friday said it is targeting a valuation of up to $956.3 million in its US initial public offering, as biotech companies press ahead with lis…
